NCT05827757View on ClinicalTrials.gov

Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients.

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

April 13, 2025

Study Completion Date

April 13, 2025

Conditions
Aging ProblemsAgingChronic Inflammation
Interventions
BIOLOGICAL

autologous adipose-derived mesenchymal stem cell transplantation

Transplant 100 million autologous adipose-derived mesenchymal stem cells at Day 0 and Day 90

Trial Locations (1)

70000

RECRUITING

DNA International Hospital, Ho Chi Minh City

Sponsors
All Listed Sponsors
collaborator

University of Science Ho Chi Minh City

OTHER

lead

DNA International Hospital

OTHER

NCT05827757 - Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients. | Biotech Hunter | Biotech Hunter